The researchers analyzed thousands of electronic medical records of older adults with both diabetes and cancer and found that those who were taking GLP-1s had lower all-cause mortality than did those who were taking another type of diabetes medication, dipeptidyl peptidase 4 inhibitors (DPP-4i)
Click here to read this study in NEJM
How to obtain the latest research advancements in the field of biopharmaceuticals
Additionally, a clinical study involving 142 participants showed that daily consumption of yerba mate led to a 9.7% increase in serum paraoxonase-1 (PON-1) levels, an enzyme associated with antioxidant protection and cardiovascular benefits
A federal judge in Georgia has denied Teva Pharmaceuticals request to pause the first trial in thousands of lawsuits over its Paragard intrauterine device (IUD), which plaintiffs claim can break apart during removal
[DOI] [PMC free article] [PubMed] [Google Scholar] 4.Bell J.A., Kivimaki M., Hamer M